Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Delayed speech and language development, Global developmental delay, Attention deficit hyperactivity disorder, and Intellectual disability; and common findings: Joint hypermobility and Abnormal facial shape. 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Delayed speech and language development, Gait ataxia, Global developmental delay |
FERRY3 encodes FERRY endosomal RAB5 effector complex subunit 3 (552 aa). Component of the FERRY complex (Five-subunit Endosomal Rab5 and RNA/ribosome intermediary). Highest expression in Brain Cerebellar Hemisphere (18.2 TPM) and Cells EBV-transformed lymphocytes (15.9 TPM).
Intellectual disability, autosomal recessive 66 is associated with mutations in the FERRY3 gene on chromosome 12.
FERRY3 is classified as a druggable target with score 0.0.
Genetic testing for FERRY3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for intellectual disability, autosomal recessive 66 has been reported in the published literature.
Phenotype severity distribution: 4 always present features, 2 common features.
No clinical trials have been registered for intellectual disability, autosomal recessive 66.
8 publications have been identified in PubMed for intellectual disability, autosomal recessive 66. Research spans Review / Meta-Analysis (38%), Case Report / Case Series (25%), and Epidemiology / Natural History (25%).
Chaabouni M (2026). [PMID: 41854122](https://pubmed.ncbi.nlm.nih.gov/41854122/). *Clin Genet*. [Diagnostic / Biomarker]
Webb BD (2025). [PMID: 40662098](https://pubmed.ncbi.nlm.nih.gov/40662098/). *Genet Med Open*. [Review / Meta-Analysis]
Li Y (2025). [PMID: 40050878](https://pubmed.ncbi.nlm.nih.gov/40050878/). *Ital J Pediatr*. [Case Report / Case Series]
Dilanthi HW (2025). [PMID: 39839200](https://pubmed.ncbi.nlm.nih.gov/39839200/). *JIMD Rep*. [Epidemiology / Natural History]
Ferretti A (2025). [PMID: 40674085](https://pubmed.ncbi.nlm.nih.gov/40674085/). *Epilepsia*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Muscles | 2 | Low muscle tone (hypotonia), Generalized hypotonia |
Bones and joints | 1 | Joint hypermobility |
Head and neck | 1 | Abnormal facial shape |
Aguirre AS (2024). [PMID: 39548419](https://pubmed.ncbi.nlm.nih.gov/39548419/). *BMC Pediatr*. [Review / Meta-Analysis]
Rahimian E (2024). [PMID: 38880823](https://pubmed.ncbi.nlm.nih.gov/38880823/). *Neuroradiology*. [Epidemiology / Natural History]